Egetis Therapeutics AB (EGTX.ST) Q2 2025 Earnings

30AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.32
-0.27
-0.21
-0.16

Details

Expected EPS
-0.2252848368
Actual EPS
-0.1629720096
Surprise EPS
0.06
Surprise Percent
+27.66%

Description

Egetis Therapeutics AB (EGTX.ST) has reported earnings of -0.1629720096 per share for Q2 2025.

0 Comments

Share your thoughts